Reducing from 12mg to 9mg might resolve symptoms while maintaining substantial weight loss (26.4% at 9mg vs 28.7% at 12mg)
Together, these mechanisms contribute to a healthier metabolic profile, alleviating the burden of insulin resistance and reducing ectopic fat accumulation
TEXT ON-SCREEN: INJECTION SITES under the skin
A peptides half-life affects: How often it is taken How long it stays active How long effects may last How long it may remain detectable Some peptides have half-lives measured in minutes or hours, while others can remain active for days
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Research Dosing Protocols Based on clinical trial data, most researchers follow a gradual titration protocol: TYPICAL ESCALATION SCHEDULE: Weeks 1-4: 2mg weekly Weeks 5-8: 4mg weekly Weeks 9-12: 8mg weekly Week 13+: 12mg weekly (maintenance dose) This gradual increase helps minimize side effects while allowing the body to adjust to the compound
